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ABSTRACT 
TITLE: A review of the ethical and legal principles used in the decision 
making process for feticides at seven sites in South Africa 
 
This study set out to perform an ethical-legal analysis of the current 
practices across the seven public health centres in South Africa that 
perform feticide for congenital abnormalities. Ideally, such decisions need 
to be guided by multidisciplinary discussions with the parent(s) and the 
parties included in the team, e.g. Obstetricians, Neonatologists, Nursing, 
Genetics counsellors and Social Workers and following the ethical 
principles of beneficence and respect for autonomy. Prior to the study, it 
was unknown as to whether all seven centres were using multidisciplinary 
groups in the decision-making process and on what basis approvals were 
being granted for feticide. The objectives of the review were to assess the 
number of feticides performed, who made the decision to offer the feticide 
and for what ethical or clinical indications. The results showed that all 
public health facilities in South Africa differed in the criteria that were used 
in making the decision to offer feticide. The clinicians varied in terms of 
who was represented in the team that reviewed the cases of congenital 
abnormalities. An analysis of the literature, together with a review of the 
data received on the current practices, guided the development of an 
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ethical guideline for this service as well as making recommendations as to 
how the law could be strengthened in order to protect both health workers 
and patients.  
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CHAPTER 1 
INTRODUCTION 
1.1. INTRODUCTION 
Both medical and technological advances have contributed to the ability of 
health care workers to detect fetal abnormalities antenatally, sometimes 
raising ethical and legal dilemmas. Most prospective parents are 
overwhelmed with joy by the news of a pregnancy and value to this life is 
attached throughout the gestational period. Ultrasound techniques have 
allowed parents to view this fetus as a living being with arms, legs, a face 
and a heartbeat. These same ultrasound techniques have also allowed 
the detection of fetal abnormalities, sometimes early in the pregnancy and 
sometimes only by the third trimester (Drysdale 2002: 159). The diagnosis 
of fetal abnormalities pose challenging questions to both the health care 
workers and the prospective parents about the value of fetal life, the moral 
status of fetal life and the uncertainty of the outcome of the intervention 
that is decided upon.  
 
When a fetal abnormality is detected, a decision to terminate the 
pregnancy is offered to the parents. This could involve termination before 
the fetus is 12 weeks old or after 12 weeks in the cases where a severe 
abnormality (or abnormalities) is detected. This is in keeping with the 
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South African Choice on Termination of Pregnancy Act (1996). Once the 
fetus is viable, that is after 24 weeks, the termination can be by way of a 
feticide. The term viable is derived from the French word ‘vie’, which 
means ‘capable of living’, hence its meaning in this context is ‘capable of 
being born alive’ (BMA 2005). As a medical term, feticide is the 
destruction of a fetus as part of an induced termination where the death is 
not from natural causes or because of a spontaneous termination (Free 
Online Dictionary 2008).  The procedure usually follows either of these two 
courses of action: 1) The fetus is given potassium chloride into the heart 
or 2) the umbilical vessels are occluded by various ultrasound-guided 
techniques after which labour is induced and the fetus delivered (RCOG 
2001). 
 
It is thus important to have an ethical framework outlining how a decision 
to perform a feticide should be taken and by whom, what the clinician’s 
responsibility is towards the patient and to set ethical principles that need 
to be considered in order to justify the decisions taken. 
 
1.2. MOTIVATION FOR THE STUDY 
Most ultrasound examinations performed antenatally are by individuals 
whose expertise varies from being self-taught medical practitioners to 
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those who specialize in obstetric antenatal ultrasound scanning (Pieper 
2008: Personal communication). There are currently seven public health 
facility sites in South Africa that offer feticide for pregnancies complicated 
by fetal abnormalities. However, no clear guidelines exist on who performs 
the procedure and on what ethical, clinical or legal criteria such decisions 
should be taken. Six of these sites are attached to tertiary academic 
institutions and one site is connected to a non-academic hospital, but 
there may also be terminations performed elsewhere, including private 
hospitals. Each of these institutions may be performing the terminations 
for different indications. Moreover, the decisions for such terminations are 
made by a number of different health professionals. 
 
Ideally, a multidisciplinary team should consider all factors involved in 
cases of severe congenital abnormalities. In this way, a patient may be 
presented with a joint consensus of the benefits and burdens and thus, on 
her part, she could make an informed decision.  
 
For such reasons, it was felt that further exploration on the practice of 
feticide was required. 
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1.3. AIM and OBJECTIVES 
1.3.1 AIM 
To determine what ethical frameworks and criteria are used to approve the 
termination of pregnancy in the cases of severe congenital abnormalities 
in a viable fetus across seven sites in South Africa. 
 
1.3.2 OBJECTIVES 
 To determine how many feticides are performed annually and for 
what reasons. 
 To determine who offers the counselling, both pre- and post 
termination and what options for treatment are presented to the 
patient. 
 To review what ethical and legal criteria are being used as a policy 
document and who decides whether feticide should be offered to 
the woman. 
 To determine reasons why terminations are refused after feticide is 
offered for congenital abnormalities. 
 To develop an ethical and legal guideline or framework for the 
management of termination of pregnancy of viable fetuses. 
 To inform amendments to the law that will enable clarity on issues 
that pose ethical dilemmas to both practitioners and patients. 
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1.4 STRUCTURE OF RESEARCH REPORT 
Chapter 2 provides a literature review of the ethical and legal challenges 
faced when performing feticides for congenital abnormalities. Chapter 3 
focuses on the methodology used to achieve the objectives of the study.  
The study results are reported and interpreted in Chapter 4 and Chapter 5 
follows with recommendations. The concluding comments are presented 
in Chapter 6.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
CHAPTER 2 
LITERATURE REVIEW 
2.1. INTRODUCTION 
The termination of any fetus, regardless of gestational age or abnormality 
poses ethical questions. Key amongst these are: 1)  whether or not the 
fetus has moral status; 2) the dilemma the health professional faces in 
saving or not saving a potential life; 3) the dilemma of aborting the fetus in 
order to save the mother’s life; 4) the autonomy or non-autonomy of the 
mother to decide on behalf of the fetus; 5) the interests of the broader 
society and the plurality of the values held by that society; and 6) the laws 
that guide these decisions.  
 
In general, the ethics surrounding terminations have to weigh up absolute 
principles against more pragmatic approaches to the problem. In absolute 
terms, Kantian ethics, for example, places human dignity above all else. 
He argues that due to our ability to reason, we should all arrive at the 
same moral answer when solving ethical dilemmas, thus making this 
moral truth universalisable, irrespective of the circumstances and 
consequences (McAdoo n.d.). Thus, on the surface, Kant would argue 
against any form of termination of pregnancy. This is because of the 
inherent worth and dignity possessed by all human beings. The 
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Consequentialist argument on the other hand, makes a judgment based 
on the overall consequences of the actions to benefit the majority. For 
example, if the consequence of the birth will bring about misery for the 
majority of those involved, then the birth should be avoided and it may be 
considered a right action to abort the fetus. Alternately, if it brings 
pleasure, a good, or happiness to the greatest number of persons 
involved, then the consequentialist would reject termination of pregnancy. 
 
In attempting to justify complex circumstances such as a pregnancy 
resulting from a rape, or in cases where the fetus has a congenital 
abnormality that will result in its death after birth, or if there is a risk to the 
health of the mother resulting from the pregnancy, a more pragmatic 
approach is required. Using the absolute approach does not help to clarify 
these ‘grey’ areas, since in reality, they are always compromised by some 
or other circumstances (McAdoo n.d.). The following discussions focus on 
the circumstance of having to abort a viable pregnancy that is complicated 
by a congenital abnormality. 
 
2.2 ETHICAL CONSIDERATIONS 
The ethical arguments concerning termination of pregnancy generally 
revolve around the moral and legal status of the fetus. For some, the basis 
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of this is religious and for some secular. Various dividing lines have been 
suggested at which point the fetus is assumed to have a moral status and 
as such, it should be regarded as having the same rights as a person. 
According to one secular approach, the fetus is a person when special 
characteristics are acquired during development, such as the potential to 
be rational, the potential for intelligence, developing human anatomy and 
viability (Strong 1992:793). The possession of these differing factors such 
as the ability to plan for the future, have self awareness and build 
relationships with others, grounds the different moral rights and 
evaluations of what it means to be a human being (Gillon 1985: 1734). It is 
also said that the fetus acquires moral status progressively throughout 
pregnancy, marked by specific milestones, such as the development of 
the neural tube, various organs, the maturation of the brain and 
eventually, the birth (Paintin 2002:371). Others have identified moral 
status being conferred to the fetus when it possesses one or more intrinsic 
characteristics that make it independent of the mother and thus similar to 
a person. However, these characteristics by themselves do not confer 
personhood; for example, viability is the gestational age at which the fetus 
can survive outside the uterus, which is at 24 weeks (BMA 2005). This 
should relate to the biological factors that allow the fetus to survive, but 
ongoing technological advancements allows survival from an earlier age, 
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thereby making viability less plausible as a criterion for personhood. There 
are also no specific biological markers at which it can be said that the 
fetus develops the potential for rationality or intelligence (Chervenak and 
McCullough 1993:397).  Some philosophers have also argued that 
personhood depends on being self-conscious and since the fetus is not 
self aware, they do not have a right to life (Gillon 1985: 1736). Such a 
position does raise other ethical questions about e.g. the fetus with a 
congenital abnormality, which due to the handicap, has less of a moral 
status in terms of its capacity to become a ‘person’.  It thus remains 
unclear as to when and if the fetus can become a moral agent in terms of 
having specific characteristics and ultimately, possessing a right to life.  
 
A second approach considers a consequentialist argument that 
personhood is applicable to mature fetuses because of their similarity to 
persons and they should therefore be treated as if they were persons in at 
least the social sense (Strong 1992: 794). An alternate argument states 
that whether or not the fetus has become mature, it should be treated with 
the same moral respect as persons are treated at least with regard to 
avoiding doing anything that may harm the people they are to become 
(Gillon 1988:3).   
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It is therefore not permissible to kill a fetus that could harm the person it 
will become (viz. a potential person).  Thereby conferring moral status to 
the fetus is equivalent to that given to a person (ibid 1988:3).  
 
Vehmas (2002: 52), on the other hand, dismisses the consequentialist 
arguments and states that prospective parents who decide to procreate 
should assume a strong responsibility towards their prospective children, 
whether born with abnormalities or not. Parents assume this responsibility 
towards this vulnerable and dependent child from the moment they decide 
to reproduce. He claims that by the time that termination is considered, the 
fetus is already seen as an existing child. Termination at this stage as a 
moral duty is highly repulsive to prospective parents, since the fetus with 
mental retardation could have some prospect of a life worth living and 
therefore fulfilling the parental responsibility to giving birth to such a child 
should not be considered to be harmful (ibid: 59).  
 
Strong (1992: 794) suggests that both arguments are sound enough to 
confer moral standing to a fetus, including the right to life and therefore the 
fetus is deserving of protection, since viability occurs late in the second 
trimester. He (ibid: 800) notes that an ethical framework is therefore vital 
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in dealing with and justifying decisions taken in cases where congenital 
abnormalities exist.  
 
The principle of beneficence calls for the health care workers to seek a 
greater balance of benefit over harm (Chervenak et al. 2003: 477). This 
benefit should extend towards promoting the health of the pregnant 
woman as well as to the fetus, which in this view, has been conferred 
moral standing. However, this moral standing is also balanced in the 
context of the needs of other parties such as the father, other family 
members or the legal framework that applies to the health care workers. 
 
The principle of respect for autonomy calls for respecting the right of the 
pregnant woman to make her own decisions, based on her own set of 
values and beliefs. Part of the notion of respect for persons falls on the 
health care workers to help her make an informed decision by discussing 
all options of management such as aggressive management, non-
aggressive management, the option of dong nothing, or termination of the 
pregnancy. The discussion should also include the probability of the 
diagnosis and the possible outcomes in order for her to make an informed 
decision (Chervenak and McCullough 1990: 313). The idea of respect for 
persons does not extend to the fetus. This is because of its insufficiently 
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developed nervous system. Without this capacity, the fetus has no values 
or beliefs that are necessary for an individual to have his or her own 
perspective on his or her best interests. Both the physician and the 
parents have beneficence-based obligations to the fetus to act in his or 
her best interests (Chervenak 1985: 442).  
 
In a study by Kramer et al. (1998: 174), it was noted that patients who 
were offered termination based on a diagnosis of Down syndrome 
antenatally chose to do so only if the pregnancy was early in gestation and 
more so in older aged women. Eighty-seven percent (87%) of the women 
in this study opted for termination, while thirteen percent (13%) decided to 
continue with the pregnancy. Being autonomous also assumes that the 
decisions are made rationally and if placed in similar circumstances, the 
question does arise as to how rational a pregnant woman carrying an 
abnormal fetus is to make a decision. Regarding termination of the 
pregnancy, issues arise concerning what sort of counselling is being 
offered to her both pre and post the termination. In the South African 
context, the different languages, social beliefs and the vocabulary that 
people use in counselling further compounds the problem. These issues 
only deal with the decision to terminate a pregnancy. However, there is a 
larger aspect of the pregnant woman’s life than only having to deal with 
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the present diagnosis of an abnormal fetus. For example, they also bear 
the burden of having to disclose the problem of an abnormal fetus to 
family and friends; face fears of the challenges that may lie ahead if the 
pregnancy continues as well as come to grips with the uncertainties that 
accompany the possibility of this happening with a second pregnancy.  
 
Furthermore, the time of the termination is critical, as after 24 weeks, the 
baby could be born alive, placing an added emotional burden on both the 
parents and the caregivers (Stratham 2006: 1403). An example such as 
this emphasises the need for ongoing counselling to be addressed, as well 
as follow up discussions concerning future pregnancies (Thachuck 2007: 
513). 
 
Hollander et al. (2002: 574) have shown that the majority of fetal 
abnormalities can be diagnosed in the late first and early second 
trimesters1 of pregnancy. However, because of different abnormalities 
presenting at varying gestational ages, the 18-21 week scan2 cannot be 
abandoned, as this will still provide some answers before the age of 
viability.  
                                                 
1
 Between 10 and 16 weeks of pregnancy. The first ultrasound scan is normally done at this stage. 
2
 This ultrasound scan at 18-21 weeks of pregnancy specifically looks for features suggestive of 
congenital abnormalities that may not have been picked up at the first scan. 
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2.3 LEGAL CONSIDERATIONS 
All laws should be based on moral values (Cline 2008). Ideally, legislation 
on controversial issues like terminations of pregnancy and feticide should 
only adopted after much public debate about ‘pro-life’ and ‘pro-choice’ 
positions (Gevers 1998: 83). Thus, the plurality of societal values makes 
the regulation of the practice difficult. 
 
The South African Constitution guarantees the ‘right to life’ (1996: Clause 
11). If one is to assume that this applies to the unborn life, then according 
to the South African Choice on Termination of Pregnancy Act (1996), for 
the fetus, this right extends only partially in the second trimester of 
pregnancy (between 12 weeks and 20 weeks) and considerably in the 
third trimester (after 20 weeks), thus making assumptions about the moral 
status of the fetus at that age and conflicting with the constitutional right to 
life. In other words, the fetus is not a legal person. South African Law does 
not have any legislature specific to feticides and the South African Choice 
on Termination of Pregnancy Act (1996) restricts itself to terminations of 
pregnancy with no reference to feticide. 
According to Carstens and Pearmain (2007: 82), the South African 
Constitution provides that a child is a person under the age of 18 years, 
but is quiet on the matter of whether an unborn person is a child or not, 
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even a potential child and therefore does not confer any rights to the fetus. 
This implies that decisions related to the fetus have to be taken by another 
rational person on its behalf.  
The South African Choice on Termination of Pregnancy Act (Act 92 of 
1996) allows terminations up to and including the third trimester, for 
severe physical or mental abnormalities. Up to 12 weeks, there are no 
limitations on the reasons for the termination. After the 12th week, the 
practice requires a joint decision between the pregnant woman and her 
doctor and the clause stating that social and economic circumstances 
need to be taken into account, still allows for unrestricted access to 
terminations. After 20 weeks, the law provides some protection to the 
fetus in terms of its right to life, but leaves the decision in medical hands, 
where the medical practitioner is required to confer with another medical 
practitioner or midwife. What the law does not stipulate is how this 
decision should be taken and how the law should be balanced against 
issues of morality, which highlights the lack of guidance when a feticide 
may be indicated. This balance relates to the need to protect the fetus 
versus the need to protect the rights of the woman. One of the classic 
arguments in contemporary ethics involves the fetal versus maternal 
rights. In brief this argument relates to the conflict that arises when a 
pregnant woman may refuse treatment that the clinician may consider 
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beneficial to the fetus. The legal dimension of this conflict in general 
recognizes that a woman’s autonomous choice to refuse a recommended 
treatment should be respected and that any opposing views should be 
managed by allowing her to make an informed choice (Nelson 1992: 746). 
The balance also may be skewed towards the other side where there may 
be conflict between the patient’s autonomous decision and the physician 
view. Section 10 (1c) of the South African Choice on termination of 
Pregnancy Act (1996) stipulates that, ‘any person who prevents the lawful 
termination or obstructs access to a facility for the termination of a 
pregnancy shall be guilty of an offence and liable on conviction to a fine or 
to imprisonment for a period not exceeding 10 years’.  
 
Thus, health workers may have the right to refuse to perform terminations 
of pregnancy, but they do not have the right to prevent access to such 
services. However, this right to refuse care is inferred but not stipulated as 
a right to conscientious objection in the Act and this could be seen as a 
shortcoming in the law in terms of protecting the rights of the health 
worker.  Savulescu (2006: 297) believes that the individual’s values should 
have a different role in their public and private lives and that as public 
servants, doctors should act in the public interests, not their own. On the 
other hand, while conscientious objection is a human right, we are living in 
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a complex developing world. The right to conscientious objection is an 
individual right, not an institutional right and the duty to refer patients to a 
facility where the service can be provided can become difficult in a setting 
such as South Africa, hence this right needs to be balanced against the 
health hazard of unsafe terminations, thereby limiting conscientious 
objection (van Bogaert 2002: 143).  
 
Legally, there is also confusion regarding the definition of viability of a 
fetus, thereby leading to confusion about feticides and a blurring of the 
dividing line between termination of pregnancy and feticide. Viability is 
considered as having a chance of long-term survival with or without 
medical help outside of the uterus (Free Online Dictionary 2008). Over the 
past two decades, survival has improved due to advances in prenatal, 
perinatal and postnatal healthcare (Seri and Evans 2008: 4). They 
describe the survivability limit to be at 23 weeks of gestation or at 500g. 
The South African Society of Obstetricians and Gynaecologists (SASOG) 
do not offer any guidance on when the fetus is considered to be viable and 
are silent on the issue of feticide. Internationally, The Royal College of 
Obstetricians and Gynecologists (RCOG) state that any termination of 
pregnancy after 21 weeks and six days of gestation should ensure that the 
fetus is born dead, thus using more than 22 weeks as the age of viability 
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(RCOG 2001). However, with regard to viability, the RCOG suggests that 
the management should be in accordance with the British Association of 
Perinatal Medicine’s framework for Practice (RCOG 2001). The British 
Medical Association of Perinatal Medicine considers infants born between 
22 to less than 28 weeks (between 500g and 1000g in weight) of gestation 
to be viable. They add that an age cut of is difficult to define in terms of 
viability, since factors such as birth weight, multiple pregnancies and the 
gender of the fetus also affect the likely outcome. Fetal viability therefore 
relates to the minimum stage at which the fetus is able to survive (BMA 
2005). 
 In the developing world, viability is placed at 1000g or 26 to 28 weeks 
(Personal communication with Obstetricians). However, even within the 
developing world in certain regions, for example South Africa, there are 
vast disparities in social circumstances and in these situations 
considerations with regard to gestational age and viability would be largely 
dependent on whether the woman attended the public or the private 
sector. Thus, the stipulation of a gestational range presents a grey zone 
within which survival and outcome are difficult to predict and hence the 
line between patient autonomy and medical futility becomes blurred (Seri 
and Evans 2008: 7).  
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Internationally, a stillbirth is regarded as the death of a fetus weighing 
more than 500g, which is about 22 weeks of gestation (PEP 2007: 6). In 
South Africa, all infants weighing 500g or more are potentially viable (that 
is having a reasonable chance of survival if born alive), but the 
Department of Home Affairs uses 26 weeks as the gestational age after 
which all stillbirths have to be registered as a death and be issued a death 
certificate (Department of Home Affairs: 1999). They do not stipulate a 
weight. Being viable means having a chance of life and therefore having 
access to ventilation and intensive care if born alive. However, in the 
South African setting, because of resource constraints and a high mortality 
rate, public hospitals use the cut off weight at 1000g to offer ventilation 
and those less than 1000g are provided with only supportive care 
(Personal communication with Neonatologists). 
 
It has been shown that the survival of infants born after 24 weeks has 
improved since the early 1990’s, but that there may be a significant risk of 
disability, ranging from 67% at 23 weeks, 38% at 24 weeks and 20% at 25 
weeks of gestation (Rivers et al. cited in: Lee 2004: 17). There may also 
be difficulties in identifying the exact gestational age since there is a two-
week margin of error on either side. Ultrasound scanning also has a 5-day 
margin of error at 12 weeks and ±12 days at 24 weeks (ibid: 17). Legally, 
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it is therefore understandable that stipulating a cut off age or weight can 
be difficult, since this is not an exact science, but the law should reach 
some consensus on the issue, so that legal acts and guidelines do not 
contradict one another. 
 
In terms of the South African Termination of Pregnancy Act (1996), there 
would therefore be confusion for clinicians on what to do between 20 
weeks and 26 weeks. To add to the confusion, the terms ‘severe 
malformation’ and ‘risk to the fetus’ can be interpreted differently by 
different people, leading to terminations for different reasons. The term 
‘severe’ may be interpreted as life threatening to the fetus or resulting in 
significant disability (FIGO guidelines 2006: 59). In the same way, ‘risk’ 
may be a probability in that the fetus has a malformation and hence the 
possibility that this could be severe in terms of being life threatening. The 
term ‘risk’ also includes the possibility that the decision could be wrong 
since the diagnosis is based on a probability. The vagueness of these 
terms leaves the decision to terminate entirely at the discretion of the 
clinician. Problems may arise when some may consider for example a 
cleft lip to be severe enough to approve termination legally, while others 
may only recommend the procedure should the diagnosed handicap lead 
to eventual death. The South African Choice on Termination of Pregnancy 
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Act (Act 92 of 1996) is typically utilitarian in that it aims for what is 
perceived to be the best result for all concerned parties based on a 
presumption of appropriate moral and medical reasons (de Roubaix  2007: 
173).   
 
While most of the laws deal with termination of pregnancy, there are no 
national guidelines on the practice of feticide. The RCOG (1996: 3) 
developed guidelines to assist Obstetricians and Gynecologists on the 
interpretation of the law relating to terminations for fetal abnormality. In 
particular, there is some discussion about the terms ‘substantial risk’ and 
‘serious handicap’ and the legal role of the medical practitioner is 
identified. The reason for avoiding any discussion on the ethics of the 
practice are stated as the College recognising that individual Fellows and 
Members may have differing beliefs on the topic (ibid: 3). The FIGO 
guidelines (2006: 58) on the other hand touch briefly on some ethical 
aspects in the management of the severely malformed fetus and 
emphasize the need to ensure the autonomy of the mother. However, the 
guideline does not cover any ethical aspects on the practice of feticide. 
 
International consensus on the issue is also lacking in that terminations 
after viability are strictly prohibited in some countries and even within 
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different states of Australia, (de Crespigny and Savulescu 2004: 203),3 
while others, when describing risk use adjectives such as ‘significant risk’ 
and  ‘serious handicap’, further raising uncertainty (Mavroforou  2006: 186 
; Gevers 1998: 84).  
It is interesting to note that a review of comparative law pertaining to 
terminations in various countries reveal that there is no law that gives full 
moral status to the fetus. Neither is there any law that gives the fetus no 
moral status at all. French and Belgian laws allow for therapeutic 
terminations if there is a severe abnormality or there is risk to the mother, 
but they do not specify the limit on the gestational age (Chervenak and 
McCullough 1990: 311.). The uncertainty in the law may leave the doctors 
exposed to a lawsuit, for example if there is a poor outcome or a 
procedure related complication (de Crespigny  2005: 52), thus 
emphasizing the need for clarity. 
 
The past decade has seen an increase in the number of cases, especially 
in the United States, where damages are claimed from the physician for 
negligence resulting in an unwanted child or a child born with a defect. 
                                                 
3
 The article discusses the discrepancies in the laws related to terminations between the different 
states, with for example in Victoria and New South Wales, only a lethal fetal abnormality that may 
result in the death of the mother is considered grounds for an termination. The termination is thus 
performed in good faith and only to preserve the mother’s life. In Western Australia, government 
committees have to approve any terminations after 20 weeks. 
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Pertaining to this discussion, the concept of ‘wrongful birth’ needs to be 
distinguished from ‘wrongful pregnancy’ and ‘wrongful life’. ‘Wrongful 
births’ are claims brought about by the parents that they would have 
avoided conception or terminated the pregnancy had they been properly 
advised on the risks of the birth defects to the potential child (Carstens 
and Pearmain 2007: 725). This highlights the need for the physician to 
ensure that ultrasounds are performed as scheduled and that all possible 
information is shared with the parents in order for them to make an 
informed decision concerning whether or not to terminate the pregnancy 
through feticide. 
However, questions remain about who defines this risk or seriousness of 
fetal abnormalities. Surveys have shown that clinicians differ in their views 
of which abnormalities are severe enough to offer termination and as a 
result, many women’s lives are changed forever by the attitudes of their 
doctors to these controversial issues. Ethical and legal aspects of such 
decisions are seldom covered in medical journals (de Crespigny and 
Savulescu 2002: 213-214). 
 
The only recorded case in the South African legal literature is in the 
decision of Friedman v Glicksman (1996(1) SA 1134 (W), where the 
plaintiff alleged that she had asked for advice on the risks of bearing a 
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child with an abnormality. The doctor duly performed certain tests and 
informed her that there was no greater than normal risk. However, the 
plaintiff claimed that due to the doctor’s negligence and breach of his duty 
of care, a disabled child was born. The judge dismissed the plaintiff’s 
claim based on a ‘wrongful life’ by stating that 
 ‘…the South African law cannot recognise that the 
facts alleged by the plaintiff on behalf of the child are 
sufficient to sustain a cause of action and that it would 
be contrary to public policy for courts to have to hold 
that it would be better for a party not to have the 
unquantifiable blessings of life rather than to have such 
life albeit in a marred way’ and that this would open the 
door for disabled children to be entitled to sue their 
parents for allowing them to be born (Carstens and 
Pearmain 2007: 741).  
 
This ruling in itself highlights the need for ethical and legal guidelines of 
practice that will be considered acceptable, not only by the courts, but also 
by society as well as noting that legal definitions, particularly relating to 
feticides, need to be clarified and specified in terms of both ethics and the 
law.  
 25 
CHAPTER 3 
METHODOLOGY 
3.1. RESEARCH METHODOLOGY 
3.1.1.Research design 
A cross sectional study design was used to determine the objectives as 
described above. The data included descriptive and analytic components, 
where clinicians were asked their views on certain treatment methods and 
an analysis of the number and reasons for terminations was conducted in 
the form of a clinical audit. 
 
3.1.2  Sample size 
Purposive sampling was used and the study population consisted of the 
seven heads of divisions responsible for feticides within the fetal 
evaluation clinics at the relevant hospitals. The following hospitals 
currently perform feticides in South Africa: 
 Groote Schuur Hospital  
 Johannesburg Hospital 
 Tygerberg Hospital 
 Chief Albert Luthuli Hospital 
 Pretoria Academic Hospital 
 Bloemfontein Hospital 
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 East London (Cecelia Makawane) Hospital – the only non-
academic hospital. 
 
3.2. RESEARCH PROCEDURE 
3.2.1 Data collection 
The measurement tool was a semi-structured questionnaire (Appendix A) 
that was answered by the heads of the fetal assessment clinics at the 
above institutions performing feticides. The questionnaire was completed 
either by the researcher during a telephonic interview or by the participant 
and then submitted electronically after discussion, depending on their 
preference. The telephonic interviews took about twenty minutes. Since 
the cohort was small, telephonic interviews were logistically possible and 
this reduced the number of non-respondents. Initially, consent was sought 
from the Head of Department of Obstetrics and Gynaecology at the 
institutions. The study protocol together with the approval letters from the 
University of Witwatersrand Human Research Ethics Committee (Medical) 
and the University of Cape Town Research Ethics Committee was sent to 
the Heads of Department electronically, asking their permission to 
interview their respective Head of the Fetal Medicine Unit. The 
respondents were then contacted electronically to inform them of the study 
and the questionnaire and the letter of consent from their Heads of 
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Department was emailed to them before the arranged interview time. 
Following the telephonic interviews, the respondents were sent the 
competed interview forms, electronically or by fax for their records.  
 
3.2.2 Data analysis 
The data received was analysed in the following manner: 
i) The data received from the institutions was examined and is 
presented as tables. 
ii) The major ethical issues are examined in terms of ethical 
approaches thought to be relevant to the discussion as well as 
considering the recommended principles of Beauchamp and 
Childress in terms of beneficence and autonomy. 
iii) Strengths and weaknesses of each approach in this context are 
identified. 
 
3.3. LIMITATIONS OF THE STUDY 
The main limitation of this study is that it only involved the practice of 
feticides for pregnancies complicated by fetal abnormalities at public 
institutions, but did not include private hospitals and other reasons why 
feticides are performed, e.g. maternal risk, etc. thus introducing selection 
bias. Systematic bias is introduced in that the respondents possibly 
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answered the questions favourably and not in terms of the current 
practices at their institutions. This was overcome by ensuring that 
participants were aware of the confidentiality of the information provided, 
that they were sent the information prior to the interview and that further 
assurance of confidentiality was reinforced prior to the telephonic 
interview.  A further limitation is the small sample size and hence we were 
unable to conduct a formal statistical analysis.  
 
3.4. ETHICAL CONSIDERATIONS 
The study was approved by the Human Research Ethics Committees 
(Medical) of both the University of the Witwatersrand (Ref M080564 - 
Attached as Appendix B) and the University of Cape Town (Ref 203/2008 
- Attached as Appendix C). In addition, all the relevant heads of 
departments of the seven institutions gave approval for the participants to 
be contacted (Appendix D). 
 
3.4.1 Beneficence 
The study will translate into raising awareness amongst physicians of the 
complexities of the process of decision-making in this arena, which will 
result in an overall benefit to the patient. This benefit extends not only to 
the patient but also to the fetus, who is probably the primary focus of 
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discussions in pregnancies with congenital abnormalities and the balance 
of benefits is assessed both in the short and long term. 
 
3.4.2 Informed consent 
As this study involved a telephonic interview, consent was verbal. Tacit 
consent for study participation was assumed if participants responded to 
the questions asked. They were however sent the study protocol and an 
information sheet prior to the interview. The views of the participants were 
respected in terms of their responses to the questionnaire. 
 
3.4.3 Confidentiality   
The audit involved the completion of a questionnaire and to maintain 
confidentiality, no patient names, names of health care workers or 
institutions were mentioned in the report results. Since the cohort of 
participants were named and therefore specifically identified people, their 
identities could not anonymised to the researcher, however, respect for 
persons and autonomy was not infringed. In addition, they would run the 
risk of being identified as a group in publications and presentations. The 
researcher communicated this limitation both verbally and on an 
information sheet to the participants. All the hard data will be safely kept in 
the institution for six years if not published or two years in the event of a 
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publication. At the end of the two or six-year period, all information will be 
destroyed. 
 
3.5. DEFINITION OF KEY CONCEPTS (Schoeman 2000) 
 Fetus – the fetus is the stage of the development of the child that 
begins eight weeks after fertilization, when the major structures and 
organs have formed until birth. 
 Gestation – This is the period from conception to birth or the time 
during which the woman carries the developing fetus in her uterus. 
 Trimester – The nine months of pregnancy is traditionally divided 
into three trimesters roughly three months each, during which 
different phases of development of the fetus take place. 
 Congenital abnormalities – This is an anatomical or structural 
abnormality that is present at birth. 
 Feticide – the act that causes the death of the fetus that is not due 
to natural causes or the spontaneous termination of a pregnancy 
(FD 2008). 
 Gravida – This describes the number of times that a woman has 
been pregnant, for example, if it is her first pregnancy, then she is 
Gravida 1, if her second pregnancy, then Gravida 2, and so on. 
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 Parity – This describes the number of times the patient has 
delivered a fetus, whether alive or dead, beyond the gestational 
age of viability. The Parity number is usually seen with the Gravida 
number, for example, Gravida 2 Parity 1 implies that she is in her 
second pregnancy and has delivered one live birth.  
 Viability – the age at which the fetus is able to survive outside of 
the uterus (FD 2008). (Experience has shown that in the developed 
world setting, it is rare for a baby to survive whose weight is less 
than 500 grams or whose gestational age is less than 24 weeks 
and these limits are commonly used as the age of viability. 
However, in the South African public sector, survival is at 
1000grams or 28 weeks gestation, prior to which ventilation is not 
offered) (Personal communication with Obstetricians and 
Neonatologists). 
 
3.6. CONCLUSION 
The research methodology was structured in this way in order to facilitate 
the responses to be received from the seven institutions within a period of 
one month allocated to data collection.  
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CHAPTER 4 
RESULTS 
4.1 Study participants 
All the institutions that were approached responded to the questionnaire. 
Among these, one indicated that no feticides were being performed at 
their institution, thus the results are based on the information received 
from six hospitals. All the respondents are Fetal Medicine Specialists at 
their hospitals. Data for the study was collected over a period of one 
month. Three of the institutions opted to be interviewed while of the other 
three, two responded to the questionnaire electronically and one by way of 
fax. 
The small sample size including only six public hospitals poses a limitation 
in terms of generalizing the findings of the study, since the practice of 
feticide may also be occurring at other public hospitals and in private 
hospitals. However, for the public sector, considering that most cases of 
suspected abnormalities are being referred to the tertiary institutions 
according to treatment protocols, guidelines and referral criteria, it is felt 
that the views presented are representative of the main role-players 
providing this service and that these findings are an important contribution 
to the debates on this sensitive topic in Obstetrics. A similar extended 
review of private facilities would assist in gaining an understanding of the 
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practice of feticides and could provide additional insight into the ethical 
and legal challenges and changes that need to take place. 
 
4.2 Responses to questionnaire  
In this section, the responses to the six questions in the questionnaire are 
summarized in tabular form and discussed. 
 
4.2.1. Question 1: Feticide Policies 
Do you have a policy document for feticides? If yes, can this be forwarded 
to be included in the review. 
TABLE 1: Feticide policy 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Policy on 
feticides 
No Yes No Yes No No 
 
Only two of the institutions indicated that they had a written policy on the 
practice of feticides. The policies that were forwarded identify a definition 
of feticide as the procedure to be performed after viability is reached in a 
fetus with a congenital abnormality. The policies further outline why and 
how the procedure needs to be performed, who needs to be involved and 
emphasize the need for extensive counselling. Of note is that both policies 
touch on the ethical challenges that are faced in making the decision. 
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‘…If these pregnancies are terminated the baby might be born alive and 
still survive a few hours to days causing many ethical problems on the 
management.’ 
 
However, there were no specific guidelines on how to deal with the ethical 
issues. One of the policies did mention, ‘… thorough counseling and 
documentation by the fetal medicine team..’, as well as ‘..involving the 
hospital ethics committee’. Both policies cited the involvement of a panel 
of experts that would discuss the abnormality in order to make the 
decision to offer feticide. There was recognition of the distress for the 
family and the importance of compassionate care and psychological 
support were highlighted. The policy also identified that in addressing 
some of the ethical challenges, consideration needs to be given to the fact 
that the fetus would not be able to survive or would have a poor prognosis 
after birth. It should be noted that although the other institutions did not 
have a written policy on the practice, the review showed that similar 
procedures were being followed. 
 
In this type of environment, when there may be so many possibilities to 
treatment, policies should never be prescriptive, but rather serve as a 
guide that ensures the treatment of the patient in a caring and 
 35 
compassionate manner. Debates on the age of viability will remain 
ongoing, but as a starting point, there needs to be some consensus about 
this. The review clearly showed that the institutions considered viability to 
be from 22 weeks, up to 26 weeks. The group thus needs to agree on the 
gestational age of viability after which a termination of pregnancy should 
take place by means of feticide. A guideline could thus serve as a 
framework within which the service is able to function. 
 
Evidence based practice helps to guide some of the decisions that are 
made regarding feticide and while there may not be an ‘official list’ of 
conditions for this procedure, a ‘list’ develops informally as precedence is 
set. For smaller institutions, such a guide can be useful in the decision 
making process.  
 
The guideline would also need to outline the need to confer with other 
clinicians before a final decision is taken and the need for counseling and 
psychological support. At this stage, it should not be forgotten, that these 
situations also affect the caregivers and counseling sessions should be 
organized for them as well. 
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4.2.2. Question 2: Number of feticides 
How many congenital abnormalities are encountered per year and on 
average, how many of these are terminated. 
TABLE 2: Average annual number of cases presenting to the institution 
with congenital abnormalities 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Less than 12 
weeks 0  5 2  10 
12-20 weeks 15  25 10  60 
More than 
20 weeks 45  100 40  40 
 
TABLE 3:  Average annual number of terminations performed for 
congenital abnormalities 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Less than 
12 weeks 0  3 1  10 
12-20 
weeks 6  10 7  20 
More than 
20 weeks 23  30 30  10 
 
 
TABLE 4: Average annual number of feticides 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Number of 
feticides 6 10 25 6 12  
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Some institutions perform six feticides annually, while one facility did up to 
twenty-five. Of the four institutions that submitted annual estimates of the 
statistics, it was noted that the number of terminations varied from 
between 30% up to 75% per institution for fetuses with congenital 
abnormalities that were diagnosed after 20 weeks gestation.  
Of note is the lack of statistics at the institutions, providing only estimates 
of the number of procedures being performed annually, thus making a 
comparative analysis difficult. The variations in the percentage of 
terminations performed could be due to differences in presenting 
pathology in the different areas, because of diagnostic techniques used or 
the timing of the ultrasound procedures so that earlier diagnoses are 
made. Furthermore, the variation could be due to differences in the criteria 
used as an indication to perform the termination or feticide or due to 
differing counseling processes, with fewer patients refusing the offer to 
terminate. With the information requested in the questionnaire and the 
statistics provided, a definitive deduction on the variation could not be 
made, except to note the differences.  
Variation was also noted in the gestational age after which the termination 
is done as a feticide, with some institutions quoting 22 weeks and others 
only after 26 weeks. The South African Choice on Termination of 
Pregnancy Act (Act 92 of 1996) stipulates that after 20 weeks, 
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terminations may only be considered in cases of severe congenital 
malformations, if the woman’s life is endangered or if there is risk of injury 
to the fetus. The term viability is not mentioned or described, hence the 
differences in the gestational age after which feticides are considered at 
the different institutions. The need for guidance in the law is recognized. It 
is accepted that the law cannot account for every eventuality and this 
applied particularly to the practice of feticide where a decision has to be 
on a case-by-case basis. However, since there is such variability, the law 
should provide guidance on the matter.   
 
The usefulness of collecting such statistics would need to be considered 
at the institutional level, especially considering that we are in an 
environment of increasing litigation. However, this should not be the main 
impetus for such data collection, but rather that the information could be 
used as a monitoring tool to articulate where there may be areas of high 
disease burdens in terms of genetic abnormalities, lack of family planning 
or low obstetric or neonatal care. Annual reviews of such information 
would increase the knowledge base and generally help to improve the 
services. 
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4.2.3 Question 3: Decision making process to offer feticide 
If feticide is offered after 20 weeks: 
a. What are the five main indications for offering feticide 
b. Who decides that a Termination of Pregnancy (TOP)/feticide 
can be offered? (if a multidisciplinary team, then please state 
who is represented on the team) 
c. Who offers the counseling and list the treatment options offered 
to the patient? 
d. What methods are used to perform the feticide? 
e. On average, what percentage of patients accepts the feticide? 
f. What are some of the reasons for refusing an indicated TOP 
 
TABLE 5a: Decision making process to offer feticide – Main indications 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Five 
main 
indica-
tions 
Meningomyel
ocoele; 
Hydrocephal
us; 
Congenital 
infections 
and brain 
involvement; 
Microcephaly
; 
Holoprosenc
ephaly 
Trisomy 13 & 
18; Severe 
open spina 
bifida; Severe 
brain lesion; 
Bilateral severe 
renal disease 
with pulmonary 
hypoplasia; 
Multiple 
malformations 
 
Severe fetal 
malformation; 
Chromosomal 
abnormalities; 
Major structural 
abnormalities 
such as 
skeletal 
dysplasis, CNS 
or spinal, 
Amniotic band, 
Multiple 
anomolies 
Only done 
after 26 
weeks 
Trisomy 13 
&18; Severe 
intracranial 
pathology 
such as 
anencephaly 
or intracranial 
haemorrhage
; Cardiac 
abnormalities
; Dwarfism 
with skeletal 
dysplasia 
Fetal 
anomaly non 
compatible 
with life; 
Continuation 
of the 
pregnancy is 
life 
threatening to 
the mother. 
 
 40 
While the specific indications varied, feticides at all institutions were 
performed for severe cases of congenital malformation, more commonly 
Trisomy 13 and 18, severe intracranial pathology, such as hydrocephalus 
and meningomyelocele or skeletal pathology, such as skeletal dysplasia 
or spinal abnormalities and if multiple malformations were present. In 
general, significant consideration is given to the severity of the condition 
and prognosis after birth. Every case could be individualized and was 
considered separately.  
 
The indications for the terminations reflect the wide range and variability of 
the case presentations, thereby justifying the need to view each decision 
on a case-by-case basis. However, the lack of guidelines poses additional 
challenges in terms of the ethical dilemmas faced by the clinicians in 
deciding on an appropriate course of management, for example, if feticide 
is not performed prior to the termination or the birth, the baby may live for 
a few hours to days, causing distress not only to the parents, but also to 
the caregivers if treatment is withheld. Of note is that a diagnosis may 
have different degrees of severity, the milder of which may be treatable 
and therefore not considered for feticide. 
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TABLE 5b: Decision making process to offer feticide – Who decides 
 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Who 
decides 
to offer 
the TOP 
Multidisciplin
ary team  
Multi-             
disciplinary 
team  
Multi-             
disciplinary 
team 
Specialist in 
the specific 
field of the 
abnormality is 
consulted 
Multi-             
disciplinary 
team 
Multi-             
disciplinary 
team 
Who is 
represe
nt-ted 
on the 
team 
At least two 
Fetal Med 
specialists; 
Neonatologis
ts; Midwife; 
Genetic 
counsellors 
Fetal Med 
specialists; 
Paediatrician;  
Clinical 
Geneticist; 
Paediatric 
subspecialist if 
needed 
Fetal Med 
specialists; 
Obstetrician; 
Paediatrician/ 
Paed. 
Surgeon; 
Midwife; 
Genetic 
counsellors; 
Deputy Head 
of Department 
 Specialist in 
the specific 
field of the 
abnormality 
together with 
the Geneticist 
 Two 
Obstetric 
consultant
s and a 
Geneticist 
who is also 
a Paedia-
trician 
2 Fetal Med 
specialist; 
O&G 
consultant; 
Nursing sister; 
Consultant 
from the 
speciality 
where the 
problem would 
reside after 
birth. 
 
All institutions indicated that the decision to offer the patient termination 
was not taken by one person, but either in consultation with another 
specialist who is knowledgeable in the field, or by a multidisciplinary team 
including the Fetal Medicine specialist, a Paediatrician and a Geneticist or 
genetics counsellor. Only three of the institutions included a midwife in the 
team. Only after such consultation and agreement on the options available 
would the patient be counselled and allowed to make an informed 
decision. 
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The need for such consultation was verbalized by one of the respondents 
as the ethical dilemmas faced by an individual having to make such a 
decision. 
…the challenges include not having certainty of 
the diagnosis and outcome; the issues of the 
autonomy of the patients; the issues of when 
does the fetus become a patient; if the mother 
presents to us and asks for an opinion on her 
fetus, then it becomes a patient; having to do 
good for the fetus against the mother’s 
autonomy… 
Similar responses were received from other participants during the 
interview process, although the questionnaire did not specifically ask 
about the ethical dilemmas, but rather focussed on the process that is 
being followed at the various institutions. 
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TABLE 5c: Decision making process to offer feticide – Who counsels 
 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Who 
counsel
s the 
patient 
Genetic 
counsellors 
Fetal Med 
specialists;  
Geneticist; 
Paediatric 
subspecialist 
if needed; 
translator 
Fetal 
Medicine 
specialist; 
Geneticist 
with specialist 
Paediatrician 
Geneticist 
with 
Specialist 
Paediatricia
n if needed 
One 
Obstetric 
consultant 
sometimes 
with 
geneticist 
Fetal Medicine 
consultant and 
genetic 
counsellor 
 
The counselling of the patient at all institutions is done jointly between the 
Fetal Medicine, Paediatric and Genetics specialists / counsellors or 
individually by any one of these health practitioners. The indications, 
treatment options, outcomes and prognoses are presented to the patient 
who is then allowed to make an informed decision on whether or not to 
continue with the pregnancy. The treatment options offered vary with each 
individual case. 
 
‘…options always include non-termination of the pregnancy with either 
active management of the fetus (that is maximal intervention options 
prenatally or postnatally, within the context of service limitations and the 
specific disorder), or entirely an expectant approach (which includes non-
intervention to maximize the outcome for the mother, for example, 
avoiding a caesarean section for an anomaly with a poor outcome) while 
 44 
not actively terminating the fetus. For abnormalities with a definite lethal 
outcome, for example anencephaly, termination without feticide would be 
offered. Alternately, abnormalities with a chance of survival, feticide would 
be offered before the termination.’ 
 
Where there is any doubt of the diagnosis, further confirmatory tests would 
be done before considering termination or feticide. 
The South African Choice on Termination of Pregnancy Act (1996) 
(Subsections 1c; 4;5 and 6). does not specify who should be included in 
the team, except to say that the decision should be concurred by two 
medical practitioners or one medical practitioner and a midwife. The Act 
does include that the counselling should be encouraged, be non-
mandatory and non-directive and that it can be offered by either the 
medical practitioner or midwife. This is however not mandated in the act. 
 
It is important to note that each member of the team has unique expertise 
to offer the patient during the counselling process and hence the 
appropriate specialists need to be included as required. The genetic 
consultant in particular can advise the patient on the risks related to future 
pregnancies. 
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TABLE 5d: Decision making process to offer feticide – Methods used 
 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
What 
methods 
are used 
to 
perform 
the 
feticide 
Potassium 
Chloride 
injection into 
heart; 
Lignocaine 
into umbilical 
vein 
IV lignocaine 
after paralysis 
with 
pancuronium 
bromide; 
Intracardiac 
lignocaine if 
technically 
possible; 
Potassium 
Chloride 
intracardiac 
as an 
alternative 
Potassium 
Chloride 
into heart 
Potassium 
Chloride 
injection into 
heart after 
cordocen-
tesis and 
administra-
tion of 
sublimaze 
100ug.  
Dormicum 
for sedation; 
Potassium 
Chloride into 
heart 
Potassium 
Chloride 
via 
Cordocen-
tesis 
 
All the institutions indicated that Potassium Chloride was injected into the 
heart or umbilical vessels of the fetus. It has been reported that the 
umbilical route is less commonly used compared to the cardiac injection, 
but a comparative study showed that both methods are effective without 
compromising maternal safety (Bhide et al 2002: 231). The technique 
used is determined by the competency of the clinician with the selected 
procedure. All procedures are performed under ultrasound guidance. 
 
 
 
 46 
TABLE 5e: Decision making process to offer feticide – Acceptance and 
reasons for refusal 
  
 
Hospital 
A 
Hospital B Hospital C Hospital D Hospital E Hospital F 
How 
many 
patients 
accept 
the 
feticide 
offer 
75% Statistics 
not 
available 
60% 100% A few do reject 
the offer for 
feticide 
40% 
Reasons 
for 
refusal 
Religious
, 
Cultural, 
Spiritual 
beliefs 
Moral and 
religious 
objection; 
Social; 
Denial; 
Belief in 
miracles; 
Pregnancy 
too far 
advanced 
Social; 
Religious; 
Cultural; 
Belief that 
condition may 
improve; 
Family / Peer 
pressure; 
Abandonment 
by partner; 
Ability to 
collect grant 
Acceptance 
of abnormal 
child; 
Religious; 
Prognosis 
unclear 
Religious; 
Difficulty in 
making the choice 
Family 
pressure; 
Failure to 
understan
d severity 
of the 
condition 
 
The institutions varied from between a 60% to 100% acceptance rate of 
feticides. Reasons given for refusal include religious beliefs, moral and 
cultural beliefs, family or peer pressure and in some instances, denial of 
the condition with the hope of a miracle cure. One institution reported that 
termination was refused so that patients could collect social or disability 
grants. All institutions noted that the autonomy of the patient would be 
respected. 
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The reasons for the noted discrepancies could be due to the counselling 
technique used, a language barrier if English or Afrikaans is not the 
mother tongue or because of socio cultural and religious differences in the 
various communities that the different institutions serve.  
 
4.2.4 Question 4: Multidisciplinary teams 
Do you feel that all institutions should set up a Multidisciplinary Group that 
decides whether or not feticides should be performed? 
TABLE 6: Need for multidisciplinary teams 
 Hospital A Hospital B Hospital C Hospital D Hospital E Hospital F 
Need for 
Multidiscip
linary 
group 
Yes No Yes Yes Yes Yes 
Who 
should be 
represente
d in the 
group 
Obstetricia
ns; Fetal 
Medicine 
specialists; 
Geneticist; 
Paediatrici
an; 
Nursing; 
Ethicists 
initially to 
discuss 
indications 
It should 
never be a 
single 
person; 
Parental 
opinion 
important 
Fetal Medicine 
specialists; 
Obstetrician; 
Midwife; 
Geneticists; 
Paediatricians/
Surgeons;  
Ethicists; 
Psychologist; 
Social worker 
Fetal Medicine 
specialists; 
Geneticists; 
Paediatricians; 
Specialist in the 
field of 
abnormality; 
Ethicists; 
Religious 
leader 
Fetal 
Medicine 
specialists; 
Geneticists; 
Paediatrician 
from the 
subspecialty 
related to the 
problem 
Obstetrician
s; Fetal 
Medicine 
specialists; 
Genetic 
counsellor; 
Nursing; 
Specialist 
from a 
discipline 
related to 
the 
abnormality 
 
There was consensus among five of the six institutions that a 
multidisciplinary team was needed to discuss and decide whether or not to 
offer termination of a viable fetus for congenital abnormalities. However, 
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the professional categories involved would depend on the individual case, 
for example, to involve a Paediatric Cardiologist or Surgeon for a 
congenital heart anomaly. The Fetal Medicine specialist, Paediatrician and 
genetic consultant were considered to be vital in the team. Other 
suggestions included a midwife, a social worker, a psychologist, an 
ethicist and a religious leader. The team would not discuss all cases, since 
some diagnoses would be straightforward, for example, anencephaly. 
Three of the institutions suggested that there be some discussion by an 
ethics committee or that an ethicist be included in the team. One institution 
felt that a formal multidisciplinary group was not always necessary, since 
the diagnosis and expected outcome may be clear, however it was agreed 
that the decision should never be taken by one individual and that some 
consultation was needed. The patient’s legal right to termination for severe 
abnormalities was recognized in terms of the South African Choice on 
Termination of Pregnancy Act (1996) and that for viable fetuses, feticide 
was the only way to ensure a non-live birth of an affected fetus. This 
institution therefore felt that it was not up to a local committee to decide 
whether or not they supported the practice. However, discussions need to 
be held on referral policies in cases of ethical objections.  
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The doctors working in these fetal medicine units are thus faced with 
difficult scenarios and many factors would play a role in influencing their 
decisions, including their personal perspectives, what their professional 
guidance is and the institutional structure in terms of support from other 
health professionals. This assistance helps to guide the clinician in dealing 
with the conflicts of treating the mother or the fetus, the issues of fetal 
viability, of sharing the accountability and working within a legal 
framework, thereby giving support to having multidisciplinary groups 
where consensus decisions can be taken. In particular, the Fetal Medicine 
specialist, the Neonatologists or Paediatricians and Genetic specialists 
needs to be involved. The Royal College of Obstetricians and 
Gynaecologists guidelines relating to pregnancy termination practices 
suggest that the team should include Obstetricians, Neonatologists, 
midwifes and nursing staff (Coward et al. In Lee 2004: 11). 
The midwife if possible can offer her views from the perspective of what 
care would be required as well as the emotional toll this has on both the 
patient and the staff. Awareness of how such decisions get taken, knowing 
the details of the cases and being involved in the decision making process 
would only enhance the compassion in the care offered. Dedicated areas 
may be reserved for the delivery and mourning purposes, especially when 
faced with a busy labour ward. In the same way, the social worker or 
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psychologist being aware of the particular case and knowing the history of 
the situation could provide valuable assistance with pre and post 
procedure counselling as well as referring the patient to support groups 
within their communities.  
 
The role of the ethicist would also be supportive in this team, since all 
health workers are guided by ethical principles in terms of their behaviour. 
The ethicist could assist in facilitating the debates on the feasibility of 
performing the procedure as well as weighing up all available options and 
supporting what is considered best for all parties concerned in terms of the 
ethical principles of beneficence and justice. In considering issues of 
beneficence, it can be ensured that the patient will overall benefit from the 
procedure. The use of the justice principle during the deliberations will 
ensure that a fair process is followed for all those involved. At the end of 
the day, most of the decisions are clinically guided, but some 
circumstances do also require reviewing social, moral and ethical 
principles, allowing the ethicist to play a vital role. Ultimately, the third 
principle of autonomy allows the patient to make an informed decision and 
this needs to be respected. However, in the environments of resource 
constraints at such public institutions, the information given to the patient 
will include services that can be provided and that which cannot. The 
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ethicists serve an important role to guide the processes of priority setting 
and this applies to the performance of feticides as well, since if some 
babies were allowed to be born, the cost of their care to the state as well 
as their parents would need to be considered and balanced against the 
available options of care.  
 
4.2.5 Question 5: Legislation 
In your view, should the legislation be more prescriptive in terms of risk 
and disability and what specifically should be changed? 
TABLE 7: Changes to the legislation 
 Hospital A Hospital B 
Hospital 
C 
Hospital 
D 
Hospital E Hospital F 
Legislation 
more 
prescriptive 
No Yes No No No Yes, as guidelines 
 
Four of the six institutions agreed that the law should not be too 
prescriptive, since each case had to be considered individually, depending 
on the weight of the fetus, the type of abnormality and the possible 
treatment modalities available. One institution specifically requested some 
change in the legislation in order to regulate the practice of feticides in the 
private sector.  
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‘…a change is in my mind very much needed since I am aware of 
unacceptable practices regarding late terminations of pregnancies in this 
country…… to my knowledge, mainly in the private sector..’ 
While this may be true, regulations would assist to standardize practices in 
both the public and private sector. This study has acknowledged the 
exclusion of the private sector as a limitation and therefore cannot 
comment on whether or not such practices are taking place. However, 
there is some agreement that there needs to be some regulation of the 
practice of feticide. While it is accepted that the law cannot be prescriptive, 
especially relating to clinical issues such as age of viability, weight of the 
fetus and gestational age, since these factors have individual variability in 
the clinical situation. However, the law can provide guidance on these 
issues through a clause that identifies an age of viability range or definition 
and secondly to monitor the practice through a reporting mechanism, 
whereby details such as the gestational age, weight and indication for the 
feticide are recorded. The law should have a sound ethical basis in terms 
of moral values, the potential harm to the fetus once born with an 
abnormality and the right to life based on the probability of survival. It was 
felt that formal guidelines and legally binding policies would allow for a 
more ethical approach to the practice. All institutions agreed that ethical 
practices should be followed. 
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The legislation has clearly dodged this issue of feticide and speaks only of 
the conditions for terminations after 20 weeks of gestation. 
Understandably, the South African Choice on Termination of Pregnancy 
Act (1996) was not developed for the purposes of feticides and therefore 
needed to be broad, but because of the emotive nature of the practice, 
one would expect guidance in the form of regulations. The law is however 
silent on this matter.  
 
4.2.6 Question 6 – The Scenarios 
The respondents were asked to answer the scenario questions in terms of 
what they would do at their institutions. 
4.2.6.a. Scenario 1: 
42 year old, Gravida 1 Para 0, at 26 weeks gestation with a diagnosis of 
Trisomy 21 and a diaphragmatic hernia. 
Management options included: 
a. Do Nothing 
b. Offer termination 
c. Offer feticide and then termination 
d. Offer pregnancy to continue, but no intensive care or resuscitation 
will be provided post delivery 
e. Offer pregnancy to continue, with full care post delivery 
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TABLE 8a: Responses to Scenario 1 
 Response 
Hospital A Offer pregnancy to continue, but no intensive care or resuscitation will be provided post delivery. 
Hospital B - Offer feticide and then termination 
- Offer pregnancy to continue, with full care post delivery 
Hospital C Offer feticide and then termination 
Hospital D Offer termination 
Hospital E 
- Feticide 
- Neonatal Hospice 
- Surgery and resuscitation after birth 
Hospital F Offer feticide and then termination 
 
4.2.6.b. Scenario 2: 
29 year old, Gravida 1 Para 0, referred from the infertility clinic, at 25 
weeks of gestation with triplets. Findings on ultrasound show that baby A 
has hydrocephalus, while babies B and C are normal. 
Management options included: 
a. Do Nothing 
b. Offer feticide of Baby A 
 
TABLE 8b: Responses to Scenario 2 
 Response 
Hospital A Offer feticide of Baby A  at 32 weeks 
Hospital B More information is needed since hydrocephaly may have a variable prognosis 
Hospital C Offer feticide of Baby A  after 28 weeks 
Hospital D 
If there is no Polyhydramnios, the Hydrocephalic baby will delay feticide till 
just before delivery. At 25 weeks, a dead fetus can put the pregnancy at 
risk. 
Hospital E Offer feticide of Baby A  
Hospital F Offer feticide of Baby A  at 32 weeks 
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4.2.6.c. Scenario 3: 
42 year old, Gravida 3 Para 1, at 30 weeks gestation. Ultrasound findings 
show a cleft lip and palate with a ventricular septal defect of the heart. 
Management options included: 
a. Do Nothing 
b. Offer termination 
c. Offer feticide and then termination 
d. Offer pregnancy to continue, but no intensive care or resuscitation 
will be provided post delivery 
e. Offer pregnancy to continue, with full care post delivery 
 
TABLE 8c: Responses to Scenario 3 
 Response 
Hospital A Offer pregnancy to continue, with full care post delivery. 
Hospital B 
- Do nothing, just counsel and inform the parents and offer ongoing 
support 
- Offer pregnancy to continue, with full care post delivery. 
Hospital C 
Offer karyotype, if normal then continue with pregnancy at tertiary level. If 
abnormal, then offer feticide then termination. Important to respect the 
patient’s wishes. 
Hospital D 
Offer pregnancy to continue, with full care post delivery. Parents should be 
counselled. Both defects have a good prognosis if there is no genetic 
abnormality 
Hospital E 
Offer pregnancy to continue, with full care post delivery. The decision 
depends on whether the chromosome karyotype is normal. If abnormal, 
then most likely due to Trisomy 18, in which case feticide would be offered. 
Hospital F Offer pregnancy to continue, with full care post delivery. 
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4.2.6.d. Scenario 4: 
21 year old, Gravida 1 Para 0, at 24 weeks gestation. Ultrasound findings 
show possible overriding aorta, bilateral polydactly from the heels. 
Amniocentesis confirms Trisomy 13. 
Management options included: 
a. Do Nothing 
b. Offer termination 
c. Offer feticide and then termination 
d. Offer pregnancy to continue, but no intensive care or resuscitation 
will be provided post delivery 
e. Offer pregnancy to continue, with full care post delivery 
 
TABLE 8d: Responses to Scenario 4 
 Response 
Hospital A Offer termination 
Hospital B 
- Offer termination 
- Offer feticide and then termination 
- Offer pregnancy to continue, but no intensive care or resuscitation 
will be provided post delivery 
Hospital C Offer feticide and then termination 
Hospital D Offer termination 
Hospital E Offer feticide and then termination 
Hospital F Offer termination 
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4.2.6.e. Scenario 5: 
40 year old, Gravida 4 Para 0, at 32 weeks gestation. Ultrasound findings 
show hydrocephalus and a meningomyelocele. 
Management options included: 
a. Do Nothing 
b. Offer termination 
c. Offer feticide and then termination 
d. Offer pregnancy to continue, but no intensive care or resuscitation 
will be provided post delivery 
e. Offer pregnancy to continue, with full care post delivery 
 
TABLE 8e: Responses to Scenario 5 
 Response 
Hospital A Offer feticide and then termination 
Hospital B Much more information needed to reach a decision 
Hospital C Offer feticide and then termination 
Hospital D Offer feticide and then termination 
Hospital E Offer feticide and then termination 
Hospital F Offer feticide and then termination 
 
In the five scenarios that were presented, each institution answered 
differently, with some suggesting more than one option for a particular 
scenario. It is recognized that with every case, there may be other factors 
to consider and that the respondent’s interpretation of the question guided 
the responses. It was however expected that the scenarios were clear-cut 
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enough for a consensus on the decisions, but this was not found. In some 
cases, respondents did mention that the final management decision would 
depend on certain other interventions, such as karyotype testing for the 
fetus presenting with a cleft lip and ventricular septal defect. Again, this 
identifies with the need to view each case individually, since individual 
physicians’ perceptions differ. Given these complexities in the time and 
gestational age at which the diagnosis is made, sometimes facing the 
uncertainty of the diagnosis and the different presentations that may be 
involved, it seems that having a list of conditions where a feticide should 
be performed is not possible. Any guideline would thus have to broadly 
encompass a range of situations that may arise, but at the same time 
provide a framework for clinicians to work within. 
Ail the institutions mentioned that extensive counselling was important and 
that the suggested options would be discussed with the patient that an 
informed decision could be made. Decisions would also be guided by the 
available resources to provide the care, for example, the length of time for 
prolonged ventilation or rehabilitative care that would be needed. Some 
institutions may consider themselves to be more conservative in their 
decisions, while others may be more liberal. An ethical guideline could 
thus serve as a framework within which the service is able to function, 
since there is a common goal to do what is considered best for the patient. 
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Using the ethical principles for this purpose will provide guidance along 
the pathway to a decision (Rainbow 2002).  
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CHAPTER 5 
RECOMMENDATIONS 
This review deals with the challenges facing clinicians when congenital 
abnormalities are diagnosed during pregnancy and attempts to address 
these by providing the clinician with an ethical guideline. Chervenak 
(2003:474) identifies the two basic ethical principles of beneficence and 
respect for autonomy that should inform the duty of the clinician in terms 
of the obligation to promote and protect the health related interests of the 
patient. The ethical principle of beneficence obligates the clinician to seek 
the greater balance of clinical benefit over harm for the patient, while 
respect for autonomy allows the patient to make decisions on her own 
health-related and other interests.  
 
Given the plurality of values among patient populations as well as among 
different clinicians, ethical behaviours will differ. It is generally understood 
that laws and directives may be general in nature and that they cannot 
deal with every situation that a clinician may face (World Medical 
Association Medical Ethics Manual 2005: 21). According to the manual 
(ibid: 26-31), ethical issues can be approached rationally or non-rationally. 
The Non- rational approaches include: 
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• Obedience – where the rules are followed irrespective of whether or 
not they are right.  
• Imitation – where the behaviour follows that of a role model, usually 
someone in a senior position. 
• Feeling or desire – where the behaviour depends on what one feels 
is the right thing to do. 
• Intuition – where the behaviour is determined by the immediate 
perception of the right way to act. 
• Habit – where one follows previous practices. 
The rational approaches include: 
• Deontology – where doing the right thing means treating all 
individuals equally. 
• Consequentialism – where the decision is based on an analysis of 
the likely outcome, with the choice being the one that produces the 
best outcome. 
• Virtue ethics – where the behaviour is reflected in the character of 
the decision makers and clinicians with good virtues will make good 
decisions. 
The manual further suggests that the best way to make a rational ethical 
decision is to use a combination of these principles (ibid: 30-31). 
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The following steps are proposed as a guide to ethical decision-making 
and will be used in the development of an ethical guideline for feticides.  
1. Determine whether the issue at hand is an ethical one. 
2. Consult authoritative sources such as medical association codes of 
ethics and policies and respected colleagues to see how physicians 
generally deal with such issues 
3. Consider alternative solutions in light of the principles and values they 
uphold and their likely consequences. 
4. Discuss your proposed solution with those whom it will affect. 
5. Make your decision and act on it, with sensitivity to others affected. 
6. Evaluate your decision and be prepared to act differently in future. 
 
These steps are used to structure the following proposed ethical guideline 
on the management of a diagnosis of congenital abnormalities that may 
require a feticide.  
 
5.1 Ethical guideline for feticide 
The guideline (attached as Appendix E) could be applicable to both public 
and private facilities throughout South Africa that offer feticide and can be 
used as an ethical basis for the decision making process.   
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The introduction offers some discussion on the ethical principles that need 
to be considered when faced with the diagnosis of a fetal abnormality. 
These include informed consent, respect for autonomy and beneficence-
based obligations to the fetus. In addition, the framework around which the 
discussions need to be held is outlined. The guideline then offers a 
checklist of pertinent questions, based on the WMA (2005: 31) guide to 
ethical decision making that should be considered before a final decision 
is made. The importance of involving a multidisciplinary team; of 
appropriate and informed counselling sessions with the patient; of 
ensuring that the diagnosis is confirmed and that the prognosis is 
presented as an evidence-based outcome is highlighted in the guideline.  
While this guideline serves as an ethical framework, it should be regarded 
as the minimum standard and broadened at each institutional level to 
outline the clinical procedure and what the responsibilities of the health 
professionals are. In addition, the guideline can be tailored towards other 
clinical challenges being faced by health professionals in the work 
environment. 
 
5.2 Legal changes: 
Changes to the law cannot happen based on a single recommendation 
and further consultative processes need to take place before this can be 
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envisaged.  In addition, the law will need to stipulate and be prescriptive of 
its application to both the public and private sectors. 
 
In general, the following need to be given consideration. 
5..2.1 Age of viability  
The legislation on terminations of pregnancy needs to be tightened to 
include age of viability and how the decisions for terminations should be 
conducted post viability. As a general rule, the age of viability is at 24 
weeks gestation. The South African Choice on Termination of Pregnancy 
Act (Act 92 of 1996) needs to either extend the period from 13 weeks to 
24 weeks, to include the generally accepted age of viability, instead of the 
current 13 weeks to 20 weeks, or it needs to stipulate what should be 
done between 20 and 24 weeks, when the fetus becomes viable. 
Alternately, the weight limit should be stated as a range that may be 
considered acceptable for viability. This would provide clinicians with 
some guidance from a clinical basis and assist in legally regulating a 
practice that currently is open to varying interpretations. This does not 
imply that current practice is unethical, but the results of this study do 
show some variability in the age at which feticides are performed. As 
stated earlier in the report, this study did not review services in the private 
sector, adding a further dimension of variability. 
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5.2.2 Consultation 
Of importance is the need to stipulate that consultation with certain role-
players, for example the Fetal Medicine specialist, another Obstetrician 
and a Paediatrician have to concur before a decision is taken. 
Furthermore, it needs to be stipulated that in cases of congenital 
abnormalities, genetics consultants have to review the case and offer 
advice to the patient on future pregnancies. The ethical framework of 
beneficence based obligations to the fetus need to be included in this 
section of the law or presented as a guideline. 
 
5.2.3 Monitoring and evaluation  
Once stipulated, the law should also have a process of monitoring the 
enacted legislation by requesting written reports on each feticide 
performed and the indications thereof. This could assist in monitoring that 
the legislation is being adhered to as well as serve to assess the 
indications for the feticides. For this process to provide benefit, the 
necessary administrative functions would need to be in place. 
 
5.2.4 Case histories and incidentation 
There should not be a ‘list’ of diagnoses, but rather to allow the clinicians 
to review and take decisions on case histories. However, once reported, 
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the legislation should stipulate an annual national audit in order to ensure 
that the identified diagnoses are warranted for the performance of 
feticides. 
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CHAPTER 6 
CONCLUSION 
Using an ethical framework is essential in the decision making process on 
the outcome of pregnancies complicated by fetal abnormalities. This 
review has highlighted that at the six public institutions that participated in 
this study, it was noted that there were discrepancies in the way in which 
the practice of feticide is performed. The review also concludes that this is 
mainly due to a lack of clear ethical guidelines and legal direction.  
 
Of note was that the age of viability should be an important determining 
factor. There was a strong view that the decision needs to be taken by a 
multidisciplinary group of specialists who through their expertise and use 
of evidence based practice can assist in reaching a more ethically 
acceptable decision. 
 
As an objective of this study was to develop an ethical guideline, this 
together with the legal recommendations for change will assist the 
clinician in balancing his responsibility to the patient in terms of her 
autonomy and his beneficence based obligation to her and to the fetus as 
a patient with moral standing.  
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This will only serve as a guide in that the final outcome or decision should 
be made on a case-by-case basis and will depend on the type of anomaly, 
the prognosis and the reliability of the diagnosis that is made 
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APPENDICES 
Appendix A 
QUESTIONNAIRE 
 
Name of Hospital: 
_________________________________________________ 
 
1. Do you have a policy document for feticides?          Yes            No 
(If yes, can this be forwarded to me to be included in the review?)     
 
2. How many congenital abnormalities are encountered per year and how 
many of these are terminated (or on average): 
- Less than 12 weeks ________     Terminated: ____________ 
- 12-20 weeks             ________    Terminated: ____________ 
- 20 + weeks       ________     Terminated: ____________ 
      Feticide :     ____________ 
(If possible, please provide stats from your institution for at least the last 
three years) 
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3. If feticide is offered after 20 weeks: 
- What are the 5 main indications for offering feticide  
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________ 
Who decides that a TOP/feticide can be offered? (if a 
multidisciplinary team, then please state who is represented on the 
team) 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
Who offers the counselling and list the treatment options offered to 
the patient? 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
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_____________________________________________________
What methods are used to perform the feticide? 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
On average, what percentage of patients accepts the feticide? 
_____________________________________________________
What are some of the reasons for refusing an indicated TOP? 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________ 
 
4. Do you feel that all institutions should set up a Multidisciplinary Group 
that decides whether or not feticides should be performed? Yes        No 
If yes, then who should be represented on in this group? 
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
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If No, then provide reasons. 
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
5. In your view, should the legislation be more prescriptive in terms of risk 
and disability and what specifically should be changed? 
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
6. Please answer the following questions in terms of what you would do at 
your institution.  
Scenarios: Please indicate what treatment protocol will be followed in the 
following clinical situations. 
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1. 42 year old, G1 P0, at 26 weeks gestation with a diagnosis of Trisomy 
21 and a diaphragmatic hernia. 
 
            Do nothing 
Offer termination 
Offer feticide and then termination 
Offer pregnancy to continue, but no ICU/resuscitation care will be 
provided post delivery 
Offer pregnancy to continue, with full care post delivery 
 
Other options 
___________________________________________________________
___________________________________________________________ 
2. 29 year old, G1P0 patient referred from the infertility clinic, at 25 weeks 
gestation with triplets. Findings on ultrasound show that baby A has 
hydrocephalus, while babies  B & C are normal. 
            Do nothing 
Offer feticide of baby A 
 
Other options 
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___________________________________________________________
___________________________________________________________
___________________________________________________________ 
3. 42 year old G3P1, at 30 weeks gestation. Ultrasound findings show a 
cleft lip and palate with a ventricular septal defect of the heart. 
            Do nothing 
Offer termination 
Offer feticide and then termination 
Offer pregnancy to continue, but no ICU/resuscitation care will be 
provided post delivery 
Offer pregnancy to continue, with full care post delivery 
 
Other options 
___________________________________________________________
___________________________________________________________ 
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4. 21 year old G1 P0, at 24 weeks. Ultrasound findings show possible 
overriding aorta, bilateral polydactyl from the heels. Amniocentesis 
confirms Trisomy 13. 
            Do nothing 
Offer termination 
Offer feticide and then termination 
Offer pregnancy to continue, but no ICU/resuscitation care will be 
provided post delivery 
Offer pregnancy to continue, with full care post delivery 
 
Other options 
___________________________________________________________
___________________________________________________________ 
 
5. 40 year old G4 P0, at 32 weeks. Ultrasound findings show 
hydrocephalus and a meningomyelocoele. 
           Do nothing 
Offer termination 
Offer feticide and then termination 
Offer pregnancy to continue, but no ICU/resuscitation care will be 
provided post delivery 
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Offer pregnancy to continue, with full care post delivery 
 
Other options 
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Thank you for completing this questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
 
 77 
Appendix B 
 
Ethical approval from the University of the Witwatersrand 
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Appendix C 
Ethics approval from the University of Cape Town 
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Appendix D 
Approval letters from Heads of Departments. 
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Appendix E 
ETHICAL GUIDELINES FOR FETICIDES 
NOTE: This guideline serves to assist clinicians in developing institutional 
specific guidelines or policies for the practice of feticides in pregnancies 
complicated by fetal abnormalities. 
 
INTRODUCTION 
Feticides are performed for pregnancies complicated by fetal 
abnormalities when the gestational age has reached viability or above 24 
weeks. These guidelines serve as an ethical framework or checklist to 
assist clinicians in making the decision on whether or not to suggest 
feticide as a treatment option to the patient. The most important part of the 
management of these patients includes obtaining an informed consent 
from the patient after explaining all the treatment options, thereby basing 
this entire framework on the ethical principle of respect for autonomy. 
There needs to be some emphasis on the limited access to terminations 
during the third trimester and that services function under resource 
constraints, hence not all treatments options are possible. There also 
needs to be consideration given to the health status of the mother if the 
pregnancy continues and the effect of prolonging the life of the fetus on 
her psychological well-being. 
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Management alternatives can be broadly categorized as: 
- Offer pregnancy to continue 
- Offer induction of labour in order to terminate the pregnancy 
- Offer feticide, then termination 
- Offer pregnancy to continue, but only hospice care will be provided 
after delivery 
- Offer pregnancy to continue, and full care will be provided after 
delivery. 
 
According to Chervenak and McCullough (1990:313), the approach to 
obstetric ethics incorporates beneficence based obligation to the third 
trimester fetus, which lies on a continuum from no beneficence based 
obligations through minimal beneficence based obligations to more than 
minimal beneficence based obligations. Anencephaly and triploidy are 
conditions that can be diagnosed with certainty and the outcome in these 
cases will be death or short term survival and the absence of cognitive 
development capacity. Recommending that the pregnancy be allowed to 
continue is a justified option since this will not increase the already 
unavoidable risk of death and absence of cognitive development. There is 
therefore no beneficence based obligation to propose any intervention that 
would prolong the life of the fetus. Offering termination or feticide and then 
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termination is also justified, since the death of the fetus is unavoidable and 
is already a certainty.  Chervenak (1990: 314) justifies this decision by 
saying that : ‘Preventing a future that holds no benefit for the patient does 
not harm the patient. Thus beneficence based obligations to a fetus with a 
lethal anomaly are not violated by terminating the pregnancy.’  
With conditions where there is either minimal beneficence based 
obligation to the fetus, for example in fetuses with renal agenesis, where 
there is a high probability of death as an outcome, feticide or termination 
could be recommended, or the pregnancy could be allowed to continue 
with no treatment after delivery to be offered to the neonate, since this 
would be futile intervention.  In this group, consideration would also be 
given to cases where there is a high probability of neurodevelopmental 
deficit.  
Any fetus with a prognosis of expected survival following intervention and 
some deficit in neurodevelopment justifies more than minimal beneficence 
based obligation to the fetus, with the intervention offering benefit. An 
example of this includes a fetus with a diagnosis of diaphragmatic hernia 
or a ventricular septal defect that may be repaired surgically post delivery. 
The decision would be guided by the severity of the problem and 
knowledge of the probability of any severe physical or mental handicap. 
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While these obligations act as a guide to recommending the best possible 
treatment to the patient, all possibilities need to be discussed with her and 
her final decision should be respected. Thus, the beneficence based 
obligations to the fetus need to balanced against the beneficence based 
obligations and autonomy of the pregnant woman (Chervenak and others 
2003: 476). Consideration should also be given to the health risks to the 
mother if the pregnancy continues and balancing the rights of the mother 
against those of the fetus. At all times during and after the pregnancy, 
there needs to be an ongoing dialogue with the patient.  
 
GUIDELINE 
5.1.1: Determine whether the issue at hand is an ethical one. 
This would involve clearly stating when the circumstance becomes a 
problem in terms of identifying the gestational age of viability and having 
specific criteria by which the management of the pregnancy should include 
the performance of a feticide.  Ideally, an early diagnosis will be less 
complicated in terms of ethical decision making than a diagnosis that is 
only made post viability. Obstetric practices such as early ultrasound and 
referral procedures need to be in place in order to ensure this. 
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5.1.1.1. Assessment of the problem 
- Is the gestational age less than or above 24 weeks 
- If below 24 weeks, then the fetus is pre-viable and the management 
should be according the South African Choice on Termination of 
Pregnancy Act (Act 92 of 1996)  
- If above 24 weeks, then consideration needs to be given to the 
following criteria in order to decide if a feticide is indicated or not. 
 Is there certainty of the diagnosis 
 Is there certainty of death as an outcome of this anomaly 
 Is there certainty of a significantly compromised 
neurodevelopmental outcome of this anomaly. 
 What is the variability in terms of the probabilities for each of the 
above. If there is a lack of certainty, then the decision should be 
based on a high index of probability with care that can be 
provided within the resource constraints. 
 Would the continuation of this pregnancy place the mothers 
health at risk 
 
5.1.2. Consult authoritative sources such as medical association codes of 
ethics and policies and respected colleagues to see how physicians 
generally deal with such issues. 
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5.1.2.1 Confirm the diagnosis. 
 - Has a confirmatory ultrasound been done. 
- Has an amniocentesis and karyotyping, if necessary, confirmed the 
diagnosis. 
5.1.2.2   Verify the problem 
- Has a second specialist concurred with the diagnosis. 
5.1.2.3 Consult with other specialists who are knowledgeable on the 
condition. 
5.1.2.4 Review the literature for evidence based practice on feticides and 
the outcomes for similar conditions.  
 
Facts that are relevant to the problem need to be identified, scrutinized 
and confirmed as reliable. This includes ensuring that all confirmations 
have been conducted in the form of ultrasound testing and further testing 
as deemed necessary by utilizing antepartum and intrapartum diagnostic 
modalities as available. At this stage, the facts have to outweigh the 
opinions. Besides the relevance of the facts, an ‘environmental’ scan is 
required, which could include maternal health risk, previous history, family 
history, exposure to hazardous substances, among others. 
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5.1.3. Consider alternative solutions in light of the principles and values 
they uphold and their likely consequences. 
- Should the pregnancy be allowed to continue 
- Should the pregnancy be terminated through induction of labour 
- Should feticide be offered, and then terminated  
- Should the pregnancy continue but no treatment offered after birth 
- Should the pregnancy continue with full treatment offered after birth 
 
5.1.3.1 List all the options 
The multidisciplinary team including the Fetal Medicine specialist, the 
second Obstetrician, the Neonatologist / Paediatrician, the Geneticist and 
Midwife meet to discuss the options, benefits and possible outcomes 
based on sharing expertise and evidence based practice. Consideration 
should also be given to the human and financial costs related to the 
decision. 
 
Based on the assessment, an outcome has to be articulated as the best 
possible resolution given the diagnosis, the circumstances and the 
resources available. 
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5.1.4. Discuss your proposed solution with those whom it will affect. 
- Joint decision on the best available option of treatment 
- Present options to patient 
- Respect for patients’ autonomy. 
 
5.1.5. Make your decision and act on it, with sensitivity to others affected. 
- Offer extensive ongoing counselling, including genetic counselling to the 
patient. 
 
Each option is considered in terms of the institutional, provincial or 
national guideline or any relevant legal framework if available. The 
decision should also be able to withstand and be justifiable under public 
scrutiny. It should be consistent with the plurality of the values of the 
professionals, the organization and the community. The decision should 
satisfy the ethical principles of truth telling, of do no harm, adherence to 
justice and beneficence. The needs of the vulnerable and powerless fetus 
need to be considered. The final decision needs to be compatible with the 
most compelling principle identified in order to justify the chosen course of 
action, since it will set a precedent for later decisions. Adequate 
consultation should be satisfied and in the case of feticides, respecting the 
autonomy of the patient. 
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5.1.6. Evaluate your decision and be prepared to act differently in future. 
The decision and outcome should be evaluated and followed up in order 
to learn and share from the experience. 
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